News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

Icagen, Inc. (ICGN) Reiterates Its Recommendation That Stockholders Accept Pfizer Inc. (PFE)'s Offer of $6 Per Share



8/16/2011 9:57:47 AM

RESEARCH TRIANGLE PARK, N.C., Aug. 16, 2011 (GLOBE NEWSWIRE) -- Icagen, Inc. (Nasdaq:ICGN) announced today that it has mailed the following letter to stockholders reiterating its recommendation that Icagen stockholders accept the $6 per share tender offer by Pfizer Inc. (NYSE:PFE):

Read at GlobeNewswire


comments powered by Disqus
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES